Next week at SupplySide West, Gencor Nutrients Inc. (Anaheim, CA) will present the results of a new human clinical study recently completed in Australia on male libido and Testofen, Gencor's proprietary extract of fenugreek. Gencor says that the study's results show Testofen to be a safe and effective product for increasing libido in healthy males.
Next week at SupplySide West, Gencor Nutrients Inc. (Anaheim, CA) will present the results of a new human clinical study recently completed in Australia on male libido and Testofen, Gencor's proprietary extract of fenugreek. Gencor says that the study's results show Testofen to be a safe and effective product for increasing libido in healthy males.
The randomized, double-blind placebo study tested sexual function, performance, and libido levels in 60 healthy males ranging between the ages of 21 and 50, over a six-week period. Gencor says that results showed that Testofen produced a significant positive change in all parameters of libido, including sexual cognition, sexual arousal, sexual experience, and orgasm.
The company adds that the effects may also be a result of interaction with testosterone via alpha-5 reductase activity.
Details of the study will be presented at SupplySide West in a VendorWorks seminar on November 13 at 2:30 p.m.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.